Medications

Review paper compares two leading pancreatic cancer drugs

An in-depth analysis of two common treatments for advanced pancreatic cancer from The University of Toledo has found the combination chemotherapy drug Folfirinox is more likely to promote progression-free survival—a notable ...

page 1 from 40